Evidence map›Paper›PMID 28539717›Full record

ArticlePharmacognosy magazine

Caspase-mediated Apoptotic Effects of

Ece Simsek, Nilufer Imir, Esra Arslan Aydemir, Ramazan Suleyman Gokturk, Erdem Yesilada, Kayahan Fiskin

Abstract read
In one paragraph

Article in Pharmacognosy magazine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. FeIET nanobiotechnology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ece SimsekDepartment of Nutrition and Dietetics, Antalya School of Health, Akdeniz University, Akdeniz, Antalya, Turkey.
Nilufer ImirDepartment of Biology Education, Faculty of Education and Institute of Life Sciences, Akdeniz University, Akdeniz, Antalya, Turkey.
Esra Arslan AydemirDepartment of Biology, Faculty of Sciences, Akdeniz University, Akdeniz, Antalya, Turkey.
Ramazan Suleyman GokturkDepartment of Biology, Faculty of Sciences, Akdeniz University, Akdeniz, Antalya, Turkey.
Erdem YesiladaDepartment of Pharmacognosy, Faculty of Pharmacy, Yeditepe University, Atasehir, Istanbul, Turkey.
Kayahan FiskinDepartment of Biology, Faculty of Sciences, Akdeniz University, Akdeniz, Antalya, Turkey.
Yeditepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

objectiveIn the present study, we have examined the apoptotic effects of hydroalcoholic extracts of MATERIALS AND

methodsTo determine the cytotoxic effect, cells were treated with various concentrations of extracts for 24, 48, and 72 h incubation periods. Cytotoxic effects were examined by Cell Titer 96 aqueous nonradioactive cell proliferation assay and the results were corrected by live/dead viability/cytotoxicity assay and trypan blue exclusion assay. Apoptotic effects were studied with multicaspase kit. Tumor necrosis factor-alpha (TNF-α) and interferon gamma (IFN-γ) release were also measured by enzyme-linked immunosorbent assay.

resultsAccording to the results,

conclusionThe effects of the extract on caspase-3, TNF-α, and IFN-γ levels mediate the plausible mechanism of apoptosis induction in HeLa. To the best of our knowledge, this is the first report indicating any pharmacological properties of SUMMARY: HeLa cell viability was reduced in dose-dependent manner for 72 h with an IC50 of approximate 28.03 μg/mL for aerial and 41.02 μg/mL for rootHeLa cells, exposure to the aerial extract led to 1.9, 3.8, 1.2, 2.4, and 3.45 fold induction of all caspases activities (-2, -3, -6, -8, and -9, respectively)Both 30 μg/mL of aerial and 45 μg/mL of root extracts allowed the production of anticancer cytokines (TNFalpha; IFNgamma) in HeLa cell culture supernatants.

Indexed as

Apoptosiscaspasecervical cancerEbenusinterferon-gammatumor necrosis factor

Identifiers

PMID28539717
PMCPMC5421422
OpenAlexW2606019427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.